EU-funded researchers are developing innovative tools and 'liquid biopsy' techniques to improve the diagnosis and treatment of cancer by targeting the detached tumour cells that cause the vast majority of deaths. Once validated and commercialised, their approach promises to lead to more effective and personalised care for cancer patients.
from EUROPA - Syndicated Research News Feed http://ift.tt/1dZVtZW
via IFTTT
No comments:
Post a Comment